Literature DB >> 15372073

Tissue plasminogen activator is a potent activator of PDGF-CC.

Linda Fredriksson1, Hong Li, Christina Fieber, Xuri Li, Ulf Eriksson.   

Abstract

Tissue plasminogen activator (tPA) is a serine protease involved in the degradation of blood clots through the activation of plasminogen to plasmin. Here we report on the identification of tPA as a specific protease able to activate platelet-derived growth factor C (PDGF-C). The newly identified PDGF-C is secreted as a latent dimeric factor (PDGF-CC) that upon proteolytic removal of the N-terminal CUB domains becomes a PDGF receptor alpha agonist. The CUB domains in PDGF-CC directly interact with tPA, and fibroblasts from tPA-deficient mice fail to activate latent PDGF-CC. We further demonstrate that growth of primary fibroblasts in culture is dependent on a tPA-mediated cleavage of latent PDGF-CC, generating a growth stimulatory loop. Immunohistochemical analysis showed similar expression patterns of PDGF-C and tPA in developing mouse embryos and in tumors, indicating both autocrine and paracrine modes of activation of PDGF receptor-mediated signaling pathways. The identification of tPA as an activator of PDGF signaling establishes a novel role for the protease in normal and pathological tissue growth and maintenance, distinct from its well-known role in plasminogen activation and fibrinolysis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15372073      PMCID: PMC522796          DOI: 10.1038/sj.emboj.7600397

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

1.  PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor.

Authors:  E Bergsten; M Uutela; X Li; K Pietras; A Ostman; C H Heldin; K Alitalo; U Eriksson
Journal:  Nat Cell Biol       Date:  2001-05       Impact factor: 28.824

2.  The mouse Pdgfc gene: dynamic expression in embryonic tissues during organogenesis.

Authors:  H Ding; X Wu; I Kim; P P Tam; G Y Koh; A Nagy
Journal:  Mech Dev       Date:  2000-09       Impact factor: 1.882

Review 3.  Mechanism of action and in vivo role of platelet-derived growth factor.

Authors:  C H Heldin; B Westermark
Journal:  Physiol Rev       Date:  1999-10       Impact factor: 37.312

4.  PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors.

Authors:  J P Zwerner; W A May
Journal:  Oncogene       Date:  2001-02-01       Impact factor: 9.867

5.  Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor.

Authors:  D G Gilbertson; M E Duff; J W West; J D Kelly; P O Sheppard; P D Hofstrand; Z Gao; K Shoemaker; T R Bukowski; M Moore; A L Feldhaus; J M Humes; T E Palmer; C E Hart
Journal:  J Biol Chem       Date:  2001-04-10       Impact factor: 5.157

6.  The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling.

Authors:  O Nicole; F Docagne; C Ali; I Margaill; P Carmeliet; E T MacKenzie; D Vivien; A Buisson
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

Review 7.  Tissue plasminogen activator in nervous system function and dysfunction.

Authors:  S Strickland
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

8.  PDGF-D, a new protease-activated growth factor.

Authors:  W J LaRochelle; M Jeffers; W F McDonald; R A Chillakuru; N A Giese; N A Lokker; C Sullivan; F L Boldog; M Yang; C Vernet; C E Burgess; E Fernandes; L L Deegler; B Rittman; J Shimkets; R A Shimkets; J M Rothberg; H S Lichenstein
Journal:  Nat Cell Biol       Date:  2001-05       Impact factor: 28.824

9.  Chromosomal location, exon structure, and vascular expression patterns of the human PDGFC and PDGFD genes.

Authors:  M Uutela; J Laurén; E Bergsten; X Li; N Horelli-Kuitunen; U Eriksson; K Alitalo
Journal:  Circulation       Date:  2001-05-08       Impact factor: 29.690

10.  The tissue plasminogen activator (tPA)/plasmin extracellular proteolytic system regulates seizure-induced hippocampal mossy fiber outgrowth through a proteoglycan substrate.

Authors:  Y P Wu; C J Siao; W Lu; T C Sung; M A Frohman; P Milev; T H Bugge; J L Degen; J M Levine; R U Margolis; S E Tsirka
Journal:  J Cell Biol       Date:  2000-03-20       Impact factor: 10.539

View more
  80 in total

1.  tPA activates LDL receptor-related protein 1-mediated mitogenic signaling involving the p90RSK and GSK3beta pathway.

Authors:  Ling Lin; Guojun Bu; Wendy M Mars; W Brian Reeves; Sakae Tanaka; Kebin Hu
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

2.  Tissue Plasminogen Activator: Side Effects and Signaling.

Authors:  Ling Lin; Kebin Hu
Journal:  J Drug Des Res       Date:  2014-09-25

3.  Presymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration.

Authors:  Sebastian A Lewandowski; Ingrid Nilsson; Linda Fredriksson; Peter Lönnerberg; Lars Muhl; Manuel Zeitelhofer; Milena Z Adzemovic; Susanne Nichterwitz; Daniel A Lawrence; Eva Hedlund; Ulf Eriksson
Journal:  Acta Neuropathol       Date:  2015-12-19       Impact factor: 17.088

4.  A novel signaling axis of matriptase/PDGF-D/ß-PDGFR in human prostate cancer.

Authors:  Carolyn V Ustach; Wei Huang; M Katie Conley-LaComb; Chen-Yong Lin; Mingxin Che; Judith Abrams; Hyeong-Reh Choi Kim
Journal:  Cancer Res       Date:  2010-11-23       Impact factor: 12.701

Review 5.  Tissue plasminogen activator-mediated PDGF signaling and neurovascular coupling in stroke.

Authors:  E J Su; L Fredriksson; G P Schielke; U Eriksson; D A Lawrence
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

6.  Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function.

Authors:  Andre L Samson; Simon T Nevin; David Croucher; Be'eri Niego; Philip B Daniel; Thomas W Weiss; Eliza Moreno; Denis Monard; Daniel A Lawrence; Robert L Medcalf
Journal:  J Neurochem       Date:  2008-09-15       Impact factor: 5.372

7.  Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke.

Authors:  Enming J Su; Linda Fredriksson; Melissa Geyer; Erika Folestad; Jacqueline Cale; Johanna Andrae; Yamei Gao; Kristian Pietras; Kris Mann; Manuel Yepes; Dudley K Strickland; Christer Betsholtz; Ulf Eriksson; Daniel A Lawrence
Journal:  Nat Med       Date:  2008-06-22       Impact factor: 53.440

Review 8.  Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders.

Authors:  Sebastian A Lewandowski; Linda Fredriksson; Daniel A Lawrence; Ulf Eriksson
Journal:  Pharmacol Ther       Date:  2016-08-12       Impact factor: 12.310

9.  Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects.

Authors:  Kamala Kesavan; Judson Ratliff; Eric W Johnson; William Dahlberg; John M Asara; Preeti Misra; John V Frangioni; Douglas B Jacoby
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

10.  An oncogenic activity of PDGF-C and its splice variant in human breast cancer.

Authors:  Alyssa Bottrell; Yong Hong Meng; Abdo J Najy; Newton Hurst; Seongho Kim; Chong Jai Kim; Eun-Sook Kim; Aree Moon; Eun Joo Kim; So Yeon Park; Hyeong-Reh Choi Kim
Journal:  Growth Factors       Date:  2019-09-23       Impact factor: 2.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.